Core Capex To Revenue from 2010 to 2024
| CORZZ Stock | 18.19 0.69 3.94% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 0.0321676 | Current Value 0.0306 | Quarterly Volatility 0.26462803 |
Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 645.4 K, Depreciation And Amortization of 116.5 M or Interest Expense of 63.8 M, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0 or Days Sales Outstanding of 0.69. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.
Core | Capex To Revenue |
Latest Core Scientific,'s Capex To Revenue Growth Pattern
Below is the plot of the Capex To Revenue of Core Scientific, Tranche over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Core Scientific,'s Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.
| Capex To Revenue | 10 Years Trend |
|
Capex To Revenue |
| Timeline |
Core Capex To Revenue Regression Statistics
| Arithmetic Mean | 0.47 | |
| Geometric Mean | 0.30 | |
| Coefficient Of Variation | 56.04 | |
| Mean Deviation | 0.23 | |
| Median | 0.63 | |
| Standard Deviation | 0.26 | |
| Sample Variance | 0.07 | |
| Range | 0.6025 | |
| R-Value | (0.71) | |
| Mean Square Error | 0.04 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | (0.04) | |
| Total Sum of Squares | 0.98 |
Core Capex To Revenue History
About Core Scientific, Financial Statements
Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capex To Revenue | 0.03 | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.